Season two kicks off with DUTCH Chief Medical Officer Jaclyn Smeaton, ND, discussing the latest hormone testing research with President and Founder of Precision Analytical, Mark Newman, MS. Tune in to learn how "meaningful differentiation" can help providers make more personalized treatment decisions, and more.